Multidimensional Pharmacochemistry

PrefaceIntroductory Remarks1 Some Aspects of Medicinal Chemistry Today I. The Scientific Aspect II. The Multidimensional View III. Innovation Problems in Drug Design and Public Opinion2 Biochemical-Pharmacological Design I. Ariëns's Three Phases of Drug Action II. Spanning Biosystem-Parameter Space III. Influencing the Pharmacokinetic-Toxokinetic Phase through Molecular Manipulation IV. The Pharmacodynamic-Toxodynamic Phase V. Pharmacological-Toxicological Data Banks VI. Concluding Remarks3 Underlying Theory of Multivariate Statistics I. Definition of Statistical Terms II. The Structure of a Multivariate Design III. The MASCA Approach IV. If Many Biological Responses Must Be Analyzed, Why Can Many Univariate Approaches Not Be Employed? V. Multivariate Test Criteria and Significance Points VI. Requirements and Robustness of Multivariate Approaches VII. Operator Equations VIII. Recognition and Predictability IX. Concluding Remarks4 Multivariate Bioassay I. General Remarks II. One-Group Case: Repeated Measurements III. Test on Outliers IV. One-Group Case: Probabilistic Principal Component Analysis (PRINCO) V. Two-Group Case: Fixed Factors VI. Two-Group Case: Repeated Measurements VII. One-Way Classification of Multivariate Variance Analysis (MANOVA) VIII. Two-Way Classification of MANOVA IX. Multivariate Correlation and Regression Analysis (KANORA) X. Multivariate Covariance Analysis (MACOVA) XI. Multivariate Autocorrelation (MARA) XII. Analysis of Discrete Data XIII. Concluding Remarks5 Unity through Diversity I. Goal of the Analysis II. PRINCO III. KANORA IV. MANOVA and DISCRA V. CLASCA6 Physicochemical Parameters I. Synthesis Design II. Molecular Structure Coding III. "Multidimensionality" in Describing Substituent Effects IV. Physicochemical Data Banks V. Concluding Remarks7 The Multivariate Quantitative Structure-Activity Relationship I. Introduction to Univariate QSAR II. Principal Component Regression Analysis (PCRA) III. Overall-Response (OR) Parameter Analysis IV. KANORA Applied to QSAR V. Generalized Parabolic Model (Response Surface Optimization) VI. Grouped Observations VII. Summary8 Discussions and Future Perspectives in Multidimensional PharmacochemistryReferencesIndex